Takayuki Ohkuri
8PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 24, 2025
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1-Mutant Lung Cancer.Toshiyuki Tenma, Ryohei Yoshida, Hiraku Yanada
|Jan 27, 2024
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.Toshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi
|Dec 10, 2022
Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8+ T-cell functions via modulating glucose metabolism of CD11b+ Ly6G+ cells.Akemi Kosaka, Yuki Yajima, Shunsuke Yasuda
|Oct 26, 2022
Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulation.Hiroki Komatsuda, Risa Wakisaka, Michihisa Kono
|May 17, 2022
A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity.Yuki Yajima, Akemi Kosaka, Kei Ishibashi
|Sep 24, 2021
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes.Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato
Pageof 2
Frequent Collaborators
5 joint publications
Takumi Kumai
3 joint publications
Toshihiro Nagato
3 joint publications
Hiroki Komatsuda
2 joint publications
Takaaki Sasaki
2 joint publications
Hiroya Kobayashi
1 joint publications
Akemi Kosaka
1 joint publications
Kei Ishibashi
1 joint publications
Hidemitsu Kitamura
1 joint publications
Shunsuke Kitajima
1 joint publications
Syunsuke Yasuda
